Loading organizations...
Arcturus Capital is an EU-based private capital management firm, stewarding multi-generational family wealth. It applies an active ownership approach across private and public markets, guided by patience, integrity, and adaptability. The firm strategically invests in enterprises and assets contributing to a resilient, sustainable future, prioritizing durable value creation.
Founded on the principle of rentmeesterschap, or responsible stewardship, Arcturus Capital's insight was to create sustainable value via disciplined long-term investment. Operating privately and self-funded, the firm deliberately avoids external investors, ensuring discretion and intergenerational continuity. This reflects a core belief in patiently guiding capital over extended periods.
Arcturus Capital serves ultra-high-net-worth families, focusing on capital preservation and growth. Its long-term vision supports assets, businesses demonstrating enduring relevance and responsible stewardship, aiming for sustainable returns. The firm selectively invests in sustainable industry, established enterprises, knowledge and education, and land/heritage assets, enhancing real assets for future generations.
Arcturus Capital has 2 tracked investments across 1 company. The latest tracked deal is $12.0M Other Equity in Prolacta Bioscience in May 2007.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 23, 2007 | Prolacta Bioscience | $12.0M Other Equity | Alison DE Bord | DFJ Frontier, DFJ Mercury, Draper Associates, Funk Ventures, Gideon Hixon Fund, Phillip Capital |
| Oct 4, 2006 | Prolacta Bioscience | $5.0M Series B | — | DFJ Frontier, DFJ Mercury, Draper Associates, Draper Richards, Funk Ventures, Gideon Hixon Fund, Phillip Capital |